共 39 条
Evidence for Astrocytosis in Prodromal Alzheimer Disease Provided by 11C-Deuterium-L-Deprenyl: A Multitracer PET Paradigm Combining 11C-Pittsburgh Compound B and 18F-FDG
被引:316
作者:
Carter, Stephen F.
Scholl, Michael
Almkvist, Ove
[2
]
Wall, Anders
[3
]
Engler, Henry
[3
,4
]
Langstrom, Bengt
[5
,6
]
Nordberg, Agneta
[1
,7
]
机构:
[1] Karolinska Inst, Div Alzheimer Neurobiol Ctr, Dept Neurobiol Care Sci & Soc, S-14186 Stockholm, Sweden
[2] Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden
[3] Uppsala Univ, Dept Radiol Oncol & Radiat Sci, Uppsala, Sweden
[4] Uruguayan Ctr Mol Imaging CUDIM, Montevideo, Uruguay
[5] Uppsala Univ, Dept Biochem & Organ Chem, Uppsala, Sweden
[6] Univ London Imperial Coll Sci Technol & Med, Div Expt Med, Neuropsychopharmacol Unit, London, England
[7] Karolinska Univ Hosp Huddinge, Dept Geriatr Med, Stockholm, Sweden
基金:
瑞典研究理事会;
关键词:
Alzheimer disease;
mild cognitive impairment;
PET;
astrocytosis;
amyloid;
monoamine oxidase B;
POSITRON-EMISSION-TOMOGRAPHY;
MILD COGNITIVE IMPAIRMENT;
MONOAMINE-OXIDASE-B;
HUMAN-BRAIN;
MAO-B;
CLINICAL PROGRESSION;
MICROGLIA;
INHIBITOR;
DIAGNOSIS;
HEALTH;
D O I:
10.2967/jnumed.110.087031
中图分类号:
R8 [特种医学];
R445 [影像诊断学];
学科分类号:
1002 ;
100207 ;
1009 ;
摘要:
Astrocytes colocalize with fibrillar amyloid-beta (A beta) plaques in postmortem Alzheimer disease (AD) brain tissue. It is therefore of great interest to develop a PET tracer for visualizing astrocytes in vivo, enabling the study of the regional distribution of both astrocytes and fibrillar A beta. A multitracer PET investigation was conducted for patients with mild cognitive impairment (MCI), patients with mild AD, and healthy controls using C-11-deuterium-L-deprenyl (C-11-DED) to measure monoamine oxidase B located in astrocytes. Along with C-11-DED PET, C-11-Pittsburgh compound B (C-11-PIB; fibrillar A beta deposition), F-18-FDG (glucose metabolism), T1 MRI, cerebrospinal fluid, and neuropsychologic data were acquired from the patients. Methods: C-11-DED PET was performed in MCI patients (n = 8; mean age 6 SD, 62.6 +/- 7.5 y; mean Mini Mental State Examination, 27.5 +/- 2.1), AD patients (n = 7; mean age, 65.1 +/- 6.3 y; mean Mini Mental State Examination, 24.4 +/- 5.7), and healthy age-matched controls (n = 14; mean age, 64.7 +/- 3.6 y). A modified reference Patlak model, with cerebellar gray matter as a reference, was chosen for kinetic analysis of the C-11-DED data. C-11-DED data from 20 to 60 min were analyzed using a digital brain atlas. Mean regional F-18-FDG uptake and C-11-PIB retention were calculated for each patient, with cerebellar gray matter as a reference. Results: ANOVA analysis of the regional C-11-DED binding data revealed a significant group effect in the bilateral frontal and bilateral parietal cortices related to increased binding in the MCI patients. All patients, except 3 with MCI, showed high C-11-PIB retention. Increased C-11-DED binding in most cortical and subcortical regions was observed in MCI C-11-PIB+ patients relative to controls, MCI C-11-PIB (negative) patients, and AD patients. No regional correlations were found between the 3 PET tracers. Conclusion: Increased C-11-DED binding throughout the brain of the MCI C-11-PIB+ patients potentially suggests that astrocytosis is an early phenomenon in AD development.
引用
收藏
页码:37 / 46
页数:10
相关论文